Women’s Choice Award® Again Honors Eggland’s Best as America’s Most Recommended™ Egg
America’s #1 egg brand celebrates over a decade of superior taste and nutrition CEDAR KNOLLS, N.J., Jan. 7, 2025 /PRNewswire/ — Women across the nation have spoken once again! Year after year, the Women’s Choice Award® helps women make informed choices for their families based on
ReOrbit and Ananth Technologies Enter into Strategic Agreement on GEO Communications Satellites
Helsinki, Jan. 7, 2025 /PRNewswire/ — ReOrbit, a leading provider of software-enabled satellites for secure communications, announced the signing of a Memorandum of Understanding (MoU) with Ananth Technologies, a leading aerospace and defence manufacturer in India. This collaboration aims to e
ReOrbit and Ananth Technologies Enter into Strategic Agreement on GEO Communications Satellites
Helsinki, Jan. 7, 2025 /PRNewswire/ — ReOrbit, a leading provider of software-enabled satellites for secure communications, announced the signing of a Memorandum of Understanding (MoU) with Ananth Technologies, a leading aerospace and defence manufacturer in India. This collaboration aims to e
Avironix and Lumenier Announce Strategic Partnership to Revolutionize Drone Technology Exchange Between India and the USA
CHENNAI, India, Jan. 7, 2025 /PRNewswire/ — Avironix, a leading Indian drone innovator and manufacturer, has announced a landmark partnership with Lumenier, a renowned USA-based drone OEM, component developer and e-commerce provider. This collaboration aims to strengthen ties between the two c
Avironix and Lumenier Announce Strategic Partnership to Revolutionize Drone Technology Exchange Between India and the USA
CHENNAI, India, Jan. 7, 2025 /PRNewswire/ — Avironix, a leading Indian drone innovator and manufacturer, has announced a landmark partnership with Lumenier, a renowned USA-based drone OEM, component developer and e-commerce provider. This collaboration aims to strengthen ties between the two c
Buyback of Class B shares in Essity during week 1, 2025
STOCKHOLM, Jan. 7, 2025 /PRNewswire/ — Between December 30, 2024, and January 3, 2025, Essity Aktiebolag (publ) repurchased a total of 162,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors. The share purchase is part o
Buyback of Class B shares in Essity during week 1, 2025
STOCKHOLM, Jan. 7, 2025 /PRNewswire/ — Between December 30, 2024, and January 3, 2025, Essity Aktiebolag (publ) repurchased a total of 162,000 own Class B shares (ISIN: SE0009922164) under the framework of the buyback program as resolved by the Board of Directors. The share purchase is part o
Global Edtech Breakthrough: Mathleaks Introduces MathVizy, the First Math-Dedicated AI
STOCKHOLM, Jan. 7, 2025 /PRNewswire/ — The Swedish edtech innovator Mathleaks has launched MathVizy, the world’s first AI designed exclusively for math. For the first time, users can visualize step-by-step solutions with unparalleled clarity. “Our AI will revolutionize how math is
Global Edtech Breakthrough: Mathleaks Introduces MathVizy, the First Math-Dedicated AI
STOCKHOLM, Jan. 7, 2025 /PRNewswire/ — The Swedish edtech innovator Mathleaks has launched MathVizy, the world’s first AI designed exclusively for math. For the first time, users can visualize step-by-step solutions with unparalleled clarity. “Our AI will revolutionize how math is
U.S. FDA Granted Priority Review to Dizal’s Sunvozertinib New Drug Application
If approved, Sunvozertinib as a single oral drug would offer a convenient and safe treatment option with superior efficacy for NSCLC patients with EGFR exon20ins Sunvozertinib’s NDA was submitted based on the multinational pivotal WU-KONG1 Part B study, the results of which were presented at
